Global Gastrointestinal Therapeutics Market was valued US$ XX Mn in 2018 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX % during a forecast period.
Gastrointestinal disorders are medical conditions, which affect the colon, small & large intestine, and rectum. The disorders contain constipation, peptic ulcer diseases, and irritable bowel syndrome, which is characterized by numerous symptoms like pain, bloating, diarrhea, nausea, and vomiting.
An increase in the stress, unhealthy dietary habits, and geriatric populations drives the growth of the global gastrointestinal therapeutics market. The global gastrointestinal therapeutics market is projected to XX % rate of CAGR during the forecast period because of the increasing cases of gastrointestinal infections, aging population, and hectic lifestyle. Additionally, the unhealthy food eating habits and prevalence of sedentary lifestyle are expected to drive the growth in the gastrointestinal therapeutics market.
The generic segment is expected to grow at a XX % rate of CAGR during the forecast period. The growth in the market is attributed to the reliable expiries of patents, the cost-effectiveness of generics, and initiatives by government organizations for encouraging the usage of generics in emerging economies. Additionally, major pharmaceutical companies are constantly determined to launch generic versions of their branded counterparts to improve losses caused by patent expiration.
The Intravenous segment is estimated to hold the dominant position in the global gastrointestinal therapeutics market. The substantial share in the market is expected to grow because of its benefits associated with IV products. It is also attributed to the high price of IV products over oral products. Intravenous products contain Humira, Sandostatin, Aldurazyme, Elelyso, Naglazyme, Myozyme, Vimizim, Donnatal, Paine, Aloxi, Pepcid AC, and Remicade.
Region-wise, North America region is estimated to hold the dominant position in the global gastrointestinal therapeutics market. The dominant position in the market is attributed to the unprecedented change in lifestyle, resulting in a greater incidence of gastrointestinal diseases. The presence of government initiatives, which aimed at preventing and treating gastrointestinal diseases is expected to drive the market in the region. Additionally, the launch of a new and innovative drugs by key players and increase in uptake of the drug by consumers are expected to boost the market growth.
Branded drug key players and generic producing firms are joining forces for producing generic drugs after patent expiry, which is expected to drive the growth of generics. Additionally, major firms are progressively focusing on developing generics because of the increase in off-patented drugs in the market.
The objective of the report is to present comprehensive analysis of global gastrointestinal therapeutics market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Gastrointestinal Therapeutics Market dynamics, structure by analysing the market segments, and project the global gastrointestinal therapeutics market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the global gastrointestinal therapeutics market make the report investor’s guide.
For more information visit:https://www.maximizemarketresearch.com/market-report/global-gastrointestinal-therapeutics-market/38877/
The Scope of the Report for Global Gastrointestinal Therapeutics Market
Global Gastrointestinal Therapeutics Market, By Type
o Enzyme Replacement Therapies
o Proton-pump Inhibitors
o H2 Antagonists
Global Gastrointestinal Therapeutics Market, By Route of Administration
Global Gastrointestinal Therapeutics Market, By Application
• Ulcerative Colitis
• Crohn’s Disease
Global Gastrointestinal Therapeutics Market, By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Gastrointestinal Therapeutics Market, By Region
• North America
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in Global Gastrointestinal Therapeutics Market
• Takeda Pharmaceuticals
• Abbott Laboratories
• Allergan plc.
• Bayer AG
• Salix Pharmaceutical
• GlaxoSmithKline plc.
• Janssen Pharmaceuticals
• Pfizer Inc.
• AbbVie, Inc.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address : Pune, Maharashtra 411051, India.